SLC2A4 and chronic kidney disease: Our results demonstrated a clear reduction of insulin-stimulated glucose transport in CKD muscles (Fig 5) which is likely attributable, at least in part, by the down-regulation of muscle GLUT4 glucose transporter expression in kidney failure.